News and events
Maria Bitner-Glindzicz 2024 Early Career Researcher Awards - Application deadline Wednesday, 15 January 2025 (5pm)
We are pleased to announce that the 2024 rounds of Maria Bitner-Glindzicz 2024 ECR Awards are open for applications.
The awards are open to Early Career Researchers (PhD students, Technicians, Research Assistants, Research Fellows/Post-docs/Associates) and clinical trainees affiliated with Clinical Genetics at GOSH. All applicants must work in the area of rare or complex diseases in children.
More information on the ECR Awards (and also the Conference and Training Fund) can be found via this link: Maria Bitner-Glindzicz Awards
Tuesday, 12 November 2024: New hope to prevent blindness in children with rare genetic disease
A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialled by clinicians and researchers at UCL and Great Ormond Street Hospital, led by GGM’s Professor Paul Gissen.
Friday, 31 January 2025, 1-5pm: IEM Section Symposium and Otto Wolff Lecture
The symposium will be a hybrid event and open to all. If you are able to attend in-person, we would be delighted if you could join us for refreshments during registration from 12pm.
This year's theme is 'Unlocking the Power of Biomarkers: Advancing Diagnosis, Monitoring, and Treatment of Diseases'
The symposium will open with an Otto Wolff Lecture by Prof Simon Heales.
Registration details here
Details of past news and events
Department job opportunities
Research Assistant - closing date 05/12/2024
The project aims to compare the efficacy of 2 adeno-associated viral (AAV) vectors in a rare disease affecting the liver-based urea cycle, argininosuccinate lyase (ASL) deficiency. ASL deficieny is the second most common urea cycle disorder. This causes acute hyperammonaemia and a chronic systemic disease, affecting especially the liver with fibrosis/cirrhosis. The successful applicant will in charge of the mouse colony, assess efficacy of the neonatal AAV gene therapy, and perform liver immunostaining and analysis of biomarkers at the end of the project. Please see the job description for more details.
Close
